Posts in category All News
IL&FS Engg gains 2% after bagging order (26-08-2015)
Wall Street rally goes up in smoke, indexes end lower (26-08-2015)
Stocks in focus today: SBI, IOC, JSPL and more (26-08-2015)
The BSE Sensex was trading over 300 points down at 25,720 in early trade on Wednesday, while NSE Nifty was trading down 81 points at 7,799. At 9.59 am, Sensex was down 130.09 points at 25,902.29. Similarly, Nifty was down 24.90 points at 7,855.80 during the same time.
Below are the stocks that are likely to be in focus
Banking stocks: Bank stocks of SBI, IOB, UBI will be in focus today after government may infuse funds into these banks. SBI said it will issue equity shares on preferential basis to the government for capital infusion of Rs 5,393 crore.
IOC: State-owned Indian Oil Corp (IOC) has signed an agreement with Nepal Oil Corp (NOC) to lay a Rs 275-crore oil pipeline from Raxaul in Bihar to Amlekhgunj in Nepal.
Jindal Steel and Power Ltd (JSPL): Jindal Steel and Power Ltd (JSPL) will seek shareholders’ nod for raising up to Rs 15,000 crore via securities for loan refinancing and capital expenditure.
Dabur India: Dabur India shares will be in focus after reports said that US FDA has issued import alert to company’s Alwar Unit. Dabur India on Tuesday said that USFDA had not put any restriction on import and sale in the US, of products manufactured at its Alwar unit.
Tata Motors: Tata Motors stocks may react to China interest rates cuts move and reserve requirements as it is expected to boost sales of unit Jaguar Land Rover.
Federal Bank trades on a negative note (26-08-2015)
Sell IDBI Ltd with a stop loss of Rs 59.25: Prakash Gaba (26-08-2015)
Hitesh portfolio (26-08-2015)
Hi @hitesh2710,
Wondering why omkar is just a opportunistic bet, but not a core or emerging portfolio pick ? You know everything about this company. Just putting down my understanding here ... I see IP led growth in this company and they are continuously coming up with novel process (which they eventually patent it) to cut production cost of intermediates and get new orders from pharma companies. They are progressing good in Vet API segment as well. Only drag could be their commodity iodine business. CRISIL is continuously monitoring this company and the latest fair value of Omkr given by them is 220+. Given the expansion is also kicking in and aggressive play by technically sound father & son, shouldn't we bet on this for next 3 years at least ? Of course, with regular quarterly results monitoring.